Literature DB >> 18706530

Systemic sclerosis and infections.

Silvia Bellando Randone1, Serena Guiducci, Marco Matucci Cerinic.   

Abstract

Systemic sclerosis (SSc) is an autoimmune disease characterized by vascular obliteration, excessive extracellular matrix deposition and fibrosis of the connective tissues of the skin, lungs, gastrointestinal tract, heart, and kidneys. Numerous infectious agents (bacterial and viral) have been proposed as possible triggering factors (Parvovirus B19, Cytomegalovirus, Epstein-Barr virus, Retroviruses). Homology between viruses and autoantibody targets suggests that molecular mimicry may have a role in initiating antibody response in different disorders characterized by diffuse vascular disease, including SSc. Endothelial cell may be infected bacteria or viruses that play a particular role in inducing vasculitis. The pathogenic hypothesis include: a mechanism of molecular mimicry, the role played by endothelial cell damage, the presence of superantigens and the role of microchimeric cells. Although several studies provide important information linking infectious agents to SSc, a direct casual association between infections and SSc is still missing. In SSc viral products could synergize with other factors in the microenvironment predisposing to SSc development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18706530     DOI: 10.1016/j.autrev.2008.07.022

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  21 in total

1.  Association of the interleukin-10 1082G/A, 819C/T and 3575T/A gene polymorphisms with systemic sclerosis: a meta-analysis.

Authors:  Wen-jia Peng; Bing-xiang Wang; Hai-feng Pan; Jin-hui Tao; Jun-qing Zhang; Qian He; Chang-chun Xiao; Jing Wang
Journal:  Mol Biol Rep       Date:  2012-02-04       Impact factor: 2.316

2.  Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity.

Authors:  C Hammer; B Stepniak; A Schneider; S Papiol; M Tantra; M Begemann; A-L Sirén; L A Pardo; S Sperling; S Mohd Jofrry; A Gurvich; N Jensen; K Ostmeier; F Lühder; C Probst; H Martens; M Gillis; G Saher; F Assogna; G Spalletta; W Stöcker; T F Schulz; K-A Nave; H Ehrenreich
Journal:  Mol Psychiatry       Date:  2013-09-03       Impact factor: 15.992

Review 3.  Infections and the antiphospholipid syndrome.

Authors:  Mario García-Carrasco; Claudio Galarza-Maldonado; Claudia Mendoza-Pinto; Ricardo O Escarcega; Ricard Cervera
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

4.  Infectious aspects and the etiopathogenesis of rheumatoid arthritis.

Authors:  Michal Kasher Meron; Howard Amital; Daniel Shepshelovich; Ori Barzilai; Maya Ram; Juan-Manuel Anaya; Roberto Gerli; Nicola Bizzaro; Bizzaro Nicola; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

Review 5.  Intravenous immunoglobulins (IVIG) in systemic sclerosis: a challenging yet promising future.

Authors:  Luca Cantarini; Donato Rigante; Antonio Vitale; Salvatore Napodano; Lazaros I Sakkas; Dimitrios P Bogdanos; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2015-03       Impact factor: 2.829

Review 6.  Role of Helicobacter pylori infection in autoimmune systemic rheumatic diseases.

Authors:  Mislav Radić
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

7.  Cure of alopecia areata after eradication of Helicobacter pylori: a new association?

Authors:  Germán Campuzano-Maya
Journal:  World J Gastroenterol       Date:  2011-07-14       Impact factor: 5.742

Review 8.  Matrix metalloproteinases: a review of their structure and role in systemic sclerosis.

Authors:  Wen-jia Peng; Jun-wei Yan; Ya-nan Wan; Bing-xiang Wang; Jin-hui Tao; Guo-jun Yang; Hai-feng Pan; Jing Wang
Journal:  J Clin Immunol       Date:  2012-07-06       Impact factor: 8.317

Review 9.  Toll-like receptors in mediating pathogenesis in systemic sclerosis.

Authors:  L Frasca; R Lande
Journal:  Clin Exp Immunol       Date:  2020-02-21       Impact factor: 4.330

10.  Treatment of Rapidly Progressive Systemic Sclerosis: Current and Futures Perspectives.

Authors:  Fabian A Mendoza; Maryah Mansoor; Sergio A Jimenez
Journal:  Expert Opin Orphan Drugs       Date:  2015-11-23       Impact factor: 0.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.